Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Acta Biomater ; 171: 495-505, 2023 11.
Artigo em Inglês | MEDLINE | ID: mdl-37739250

RESUMO

Photoactivated immunotherapy has promising therapeutic efficacy for treating malignancies, especially metastatic tumors. In this study, an erythrocyte membrane-encapsulated copper indium selenium (RCIS) semiconductor nanomaterial was developed to eliminate primary and metastatic tumors, in which copper ions can induce chemodynamic performance, and the narrow band gap endows RCIS with the properties of near-infrared (NIR) light-activated photothermal and photodynamic amplified immunotherapy. Furthermore, RCIS can be used as a nanocarrier to form RNCIS nanoparticles (NPs) by loading NLG919, which blocks the indoleamine 2,3-dioxygenase-1. Under NIR light irradiation, RNCIS NPs release NLG919 at tumor sites via photothermal properties, thereby promoting the recruitment of cytotoxic T lymphocytes and M1 polarization of macrophages, targeting the activation and amplification of immune responses. Herein, in vitro and in vivo studies showed that RNCIS NPs effectively kill cancer cells and eliminate primary and metastatic tumors. Therefore, this study suggests that semiconductor nanomaterials with narrow bandgaps have great potential as photoimmunotherapy agents and NIR light-responsive nanocarriers for controlled release, providing a great paradigm for synergetic tumor photoimmunotherapy. STATEMENT OF SIGNIFICANCE: The Erythrocyte membrane-coated, NLG919-loaded copper indium selenium (RNCIS) semiconductor was designed for eliminating primary and metastatic tumors. RNCIS exhibits chemodynamic, photodynamic, and photothermal activated immunotherapy by inhibiting indoleamine 2,3-dioxygenase-1. This can enhance the recruitment of cytotoxic T lymphocyte and M1 polarization of macrophage, leading to higher synergetic photo-immune therapeutic efficacy.


Assuntos
Nanopartículas , Nanoestruturas , Neoplasias , Selênio , Humanos , Linfócitos T Citotóxicos/patologia , Selênio/farmacologia , Cobre/farmacologia , Índio , Indolamina-Pirrol 2,3,-Dioxigenase , Neoplasias/patologia , Nanopartículas/uso terapêutico , Imunoterapia , Macrófagos , Linhagem Celular Tumoral
2.
Nanoscale Res Lett ; 15(1): 188, 2020 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-32990822

RESUMO

Despite great efforts dedicated to enhance power conversion efficiency (PCE) of quantum dot-sensitized solar cells (QDSSCs) in the past two decades, the efficiency of QDSSCs is still far behind its theoretical value. The present approaches for improving PCE are mainly focused on tailoring the bandgap of QDs to broadening light-harvesting and optimizing interfaces of component parts. Herein, a new solar cell architecture is proposed by integrating concentrating solar cell (CPV) concept into QDSSCs with double photoanode design. The Cu2S mesh is used as a counter electrode and sandwiched between two photoanodes. This designed battery structure can increase the PCE by 260% compared with a single photoanode. With the most extensively used CdS/CdSe QD sensitizers, a champion PCE of 8.28% (Voc = 0.629 V, Jsc = 32.247 mA cm-2) was achieved. This is mainly due to the increase in Jsc due to the double photoanode design and adoption of the CPV concept. In addition, another reason is that concentrated sunshine illumination induced a photothermal effect, accelerating the preceding chemical reactions associated with the conversion of polysulfide species. The cell fabrication and design reported here provides a new insight for further development of QDSSCs.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA